Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Politics

FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

by March 13, 2025
March 13, 2025
FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

The Food and Drug Administration’s (FDA) top lawyer, who was appointed to the position just this week, has resigned, according to a Thursday morning post on X.

‘Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,’ the FDA’s official X account posted.  

Perkins – a former assistant director under Biden’s Department of Justice (DOJ) in the consumer protection agency – was selected on Tuesday by acting general Sean Keveney in the Department of Health and Human Services (HHS) as part of a ‘reorganization’ effort by the department, according to an HHS news release.

She previously defended abortion pill access in a high-profile case under Biden’s DOJ, and HHS officials were reportedly unhappy with the decision to appoint Perkins but were overruled by White House officials, according to a report from Axios this week.

‘We’ve been able to recruit higher quality personnel to HHS than in any time in its history,’ HHS Secretary Robert F. Kennedy, Jr., said in a statement Tuesday at the announcement of Perkins’ assignment on Tuesday. ‘These are individuals who will return the agency to gold-standard science, evidence-based medicine, and recalibrate its trajectory toward public health rather than industry profiteering.’

Fox News Digital has reached out to the HHS and FDA for comment.

This is a breaking story, check back for updates.

This post appeared first on FOX NEWS
previous post
Elon Musk’s politics are hurting Tesla, 85% say in investor survey
next post
FDA chief counsel who defended abortion pill access under Biden resigns two days into job

Related Posts

Biden White House rejects ICC sanctions proposed by...

May 29, 2024

The Hitchhiker’s Guide to potentially releasing the Ethics...

November 15, 2024

Trump’s ‘blacklist’: President-elect describes the type of people...

January 16, 2025

‘Most damning evidence’: Hunter Biden’s full pardon resurfaces...

December 6, 2024

Hamas names Yahya Sinwar, mastermind of Oct 7...

August 7, 2024

Israel warns it will go after Lebanon directly...

December 3, 2024

Congress unveils bill to avert Friday government shutdown...

December 18, 2024

Rep. Marjorie Taylor Greene to vote for Johnson...

January 3, 2025

In election victory, Trump’s gains went beyond the...

November 12, 2024

Liz Cheney fundraises off explosive Trump, Zelenskyy Oval...

March 4, 2025

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Latest News

    • Trump official targeted in Biden-era ‘disinformation’ dossier still under wraps days after Rubio revelation

      May 12, 2025
    • No millionaire tax hike in Trump’s ‘big, beautiful bill’

      May 12, 2025
    • Senior House Republican eviscerates Dems for ‘fear campaign’ against Trump’s ‘big, beautiful bill’

      May 12, 2025
    • Senate parliamentarian: Who is the unelected official getting say on Trump’s ‘big, beautiful bill?’

      May 12, 2025
    • President Trump takes on ‘Big Pharma’ by signing executive order to lower drug prices

      May 12, 2025
    • Trump defends Qatar jumbo jet offer as troubled Boeing fails to deliver new Air Force One fleet

      May 12, 2025

    Categories

    • Business (1,200)
    • Politics (5,495)
    • Stocks (904)
    • World News (454)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved